IL-6/JAK/STAT pathway is aberrantly hyper-activated in many types of cancer including ccRCC and plays a significant part in the progression of cancer cachexia through regulating the inflammatory response [32]. The gene discussed is IL6; the disease is nonpapillary renal cell carcinoma.